Italian firm Olon buys Ricerca Biosciences' chemical division

Olon SpA, the Italy-based active pharmaceutical ingredients (API) contract development and manufacturing organisation (CDMO) and generics supplier, has acquired Ricerca Biosciences’ chemical division of the contract research (CRO) and CDMO based in Concord, Ohio (USA). This acquisition strengthens the service offering of Olon for the pharmaceutical and biotech industry, and to benefits the Ricerca Biosciences customer base by providing large scale manufacturing capabilities in Europe.

“By acquiring a research and manufacturing base in the US, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop new Generic products for the American market,” commented Paolo Tubertini, CEO of Olon.